← All sarcoma trials
Opening soonN/AAges 18 Years and up

Precision Imaging to Evaluate Kaposi Sarcoma

Sponsor: Washington University School of Medicine · NCT06898203 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Kaposi Sarcoma

What it tests

  • SkinScan3Ddevice

Where it's running2 sites

2 international sites

  • Kenya Medical Research Institute

    Kisumu, Kenya

    • Elizabeth Bukusi, MBChB, MMED, MPH, PhD(contact)+254 0722 205 901[email protected]
    • Elizabeth Bukusi, MBChB, MMED, MPH, PhD(principal investigator)
    • Victor Mudhune, Bpharm(sub investigator)

  • Infectious Diseases Institute, Makerere University

    Kampala, Uganda

    • Aggrey Semeere, MBChB, MMed, MAS, FCP (ECSA)(contact)+256 772 621181[email protected]
    • Aggrey Semeere, MBChB, MMed, MAS, FCP (ECSA)(principal investigator)
    • Fred Okuku, MBChB, MMed(sub investigator)
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria - Aim 2 (Patients):

* Adults age ≥18 years old
* Histopathology-confirmed Kaposi Sarcoma
* At least 3 skin lesions
* Capable of informed consent
* On treatment for Kaposi Sarcoma

Exclusion Criteria - Aim 2 (Patients):

* Patients not initiating Kaposi Sarcoma treatment
* Very ill patients requiring hospitalization

Inclusion Criteria - Aim 3 (Patients):

* Adults age ≥18 years old
* Histopathology-confirmed Kaposi Sarcoma
* Capable of informed consent
* Initiating treatment for Kaposi Sarcoma

Exclusion Criteria - Aim 3 (Patients):

* Patients with Kaposi Sarcoma that participated in Aim 1 or Aim 2
* Prior or ongoing Kaposi Sarcoma treatment

Updated 2026-05-08 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.